Neumora Therapeutics, Inc. (NMRA) — Financial Flexibility Index
Neumora Therapeutics, Inc. (NMRA) has a Financial Flexibility Index of -1.02x as of September 2025. Free cash flow of $-46.62 Million (operating CF $-46.63 Million minus capex $16.00K) represents -1% of total liabilities ($45.67 Million). Check Neumora Therapeutics, Inc. (NMRA) tangible net worth to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Neumora Therapeutics, Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Neumora Therapeutics, Inc. across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Neumora Therapeutics, Inc. generate cash.
Annual Financial Flexibility Index for Neumora Therapeutics, Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for Neumora Therapeutics, Inc.. Explore cash flow to debt ratio of Neumora Therapeutics, Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.12x | $-182.94 Million | $-182.94 Million | $29.91 Million | ▼ -1.7% |
| 2023 | -6.02x | $-163.16 Million | $-163.28 Million | $27.12 Million | ▼ -4492.3% |
| 2022 | -0.13x | $-114.39 Million | $-114.90 Million | $873.08 Million | ▼ -32.5% |
| 2021 | -0.10x | $-74.60 Million | $-75.42 Million | $754.52 Million | ▼ -13.5% |
| 2020 | -0.09x | $-25.46 Million | $-26.76 Million | $292.33 Million | ▲ +100.0% |
| 2019 | -1212.38x | $-25.46 Million | $-26.76 Million | $21.00K | — |